|
Originally published In Press as doi:10.1074/jbc.M910340199 on March 23, 2000
J. Biol. Chem., Vol. 275, Issue 23, 17281-17287, June 9, 2000
Identification of a Novel Function of the Alphavirus
Capping Apparatus
RNA 5'-TRIPHOSPHATASE ACTIVITY OF Nsp2*
Lidia
Vasiljeva,
Andres
Merits,
Petri
Auvinen, and
Leevi
Kääriäinen
From the Program in Cellular Biotechnology, Institute of
Biotechnology, Biocenter Viikki, University of Helsinki,
FIN-00014, Helsinki, Finland
Received for publication, December 22, 1999, and in revised form, March 14, 2000
 |
ABSTRACT |
Both genomic and subgenomic RNAs of the
Alphavirus have m7G(5')ppp(5')N (cap0
structure) at their 5' end. Previously it has been shown that
Alphavirus-specific nonstructural protein Nsp1 has
guanine-7N-methyltransferase and guanylyltransferase
activities needed in the synthesis of the cap structure. During normal
cap synthesis the 5' -phosphate of the nascent viral RNA chain is removed by a specific RNA 5'-triphosphatase before condensation with
GMP, delivered by the guanylyltransferase. Using a novel RNA
triphosphatase assay, we show here that nonstructural protein Nsp2 (799 amino acids) of Semliki Forest virus specifically cleaves the
, -triphosphate bond at the 5' end of RNA. The same activity was
demonstrated for Nsp2 of Sindbis virus, as well as for the amino-terminal fragment of Semliki Forest virus Nsp2-N (residues 1-470). The carboxyl-terminal part of Semliki Forest virus Nsp2-C (residues 471-799) had no RNA triphosphatase activity. Replacement of
Lys-192 by Asn in the nucleotide-binding site completely abolished RNA
triphosphatase and nucleoside triphosphatase activities of Semliki
Forest virus Nsp2 and Nsp2-N. Here we provide biochemical characterization of the newly found function of Nsp2 and discuss the
unique properties of the entire Alphavirus-capping apparatus.
 |
INTRODUCTION |
Semliki Forest virus
(SFV)1 is member of the
Alphavirus genus of the Togaviridae family. SFV has a
positive-stranded 42 S RNA genome of 11.5 kilobases. RNA replication of
SFV takes place in the cytoplasm and is catalyzed by the viral
RNA-dependent RNA polymerase, which contains the
virus-specific proteins Nsp1-4. These are cleavage products of a large
(2342 aa) nonstructural polyprotein P1234. In the RNA polymerase
complex all Nsps are in close association with each other (1, 2). The
parental 42 S RNA is copied to complementary minus-strands, which in
turn are used as templates for the synthesis of new 42 S RNA
plus-strands and subgenomic 26 S mRNAs. During plus-strand
synthesis, the 5' ends of the 42 S and 26 S RNAs become modified with
covalently attached m7GpppA (the cap0 structure) (3-5).
Capping of the RNAs is believed to be obligatory also for the
replication of Alphavirus, since a point mutation
specifically destroying the guanylyltransferase activity of Nsp1 is
lethal for the virus (6).
The functions of Alphavirus Nsps in replication have been
studied using various genetic and biochemical approaches (1, 2). Nsp4
is the catalytic component of the RNA polymerase (7, 8), whereas the
functions of the phosphoprotein Nsp3 (9) are poorly defined (10, 11).
Nsp2 has several distinct functions. It has nucleoside triphosphatase
(NTPase) activity at its amino-terminal half (12), which is vital for
the virus replication (13). Nsp2 has RNA helicase activity, which
utilizes NTP hydrolysis as the energy source (14). The
carboxyl-terminal part of the protein is a papain-like protease
responsible for the autocatalytic cleavages of the nonstructural
polyprotein (2, 15, 16). The carboxyl-terminal part has a nuclear
localization sequence, which is responsible for sequestering of about
half of the molecules to the nucleus during infection (17, 18).
Furthermore, Nsp2 regulates transcription of the subgenomic 26 S RNA
(Ref. 19 and references therein). Here we show that Nsp2 has yet an
additional activity required for capping of the virus mRNAs.
Capping of cellular mRNAs occurs in the nucleus and comprises four
different reactions. RNA 5'-triphosphatase removes the -phosphate
from the 5' end of the nascent RNA molecule (pppRNA ppRNA).
Guanylyltransferase reacts with a GTP molecule to form a covalent
complex with GMP, which is then transferred from guanylyltransferase to
the 5' end of RNA to form G(5')ppp(5')NpRNA. Methylation by guanine-7N-methyltransferase yields an RNA molecule with the
cap0 structure (m7GpppNpRNA). Further methylation by
nucleoside-2'-O-methyltransferase of the riboses of the
penultimate and the adjacent nucleotides yields cap1 and cap2
structures, respectively (20, 21).
Unlike cellular mRNAs, the capping of Alphavirus RNAs
takes place in the cytoplasm and is carried out by reactions that
differ from the nuclear reactions as follows. (i) Nsp1 catalyzes
transfer of the methyl group from S-adenosylmethionine to
GTP to yield m7GTP (methyltransferase reaction), and (ii) a
covalent guanylate complex Nsp1-m7GMP is formed (22-25).
Here, we show that Nsp2 of SFV and Sindbis virus possess RNA
triphosphatase activity, which is localized to the amino-terminal half
of the protein. Comparison with other capping enzymes suggests that the
Alphavirus-capping apparatus is a unique complex.
 |
EXPERIMENTAL PROCEDURES |
Protein Expression and Purification--
Semliki Forest virus
nonstructural proteins Nsp1, Nsp2, Nsp3, Nsp4, the Nsp2 (K192N) mutant,
the amino-terminal part of Nsp2 (aa 1-470) (Nsp2-N), the
carboxyl-terminal part of Nsp2 (aa 470-799), and Sindbis virus Nsp2
were expressed in Escherichia coli BL21(DE3) (Stratagene)
using pHAT plasmids encoding amino-terminal His6 tags (26).
The proteins were purified using Ni2+ affinity
chromatography as described (12). Protein concentration was determined
using the Bradford assay (27) and Bio-Rad reagents. The purity of
proteins was verified by SDS-PAGE in 10% gels.
RNA Synthesis--
Two different plasmids were used to produce
RNA substrates: pGEM3Zf(+) purchased from Promega, and pUC18 . Omega
( ) leader (1-68 nucleotides) of tobacco mosaic virus was first
amplified from infectious cDNA clone tobacco mosaic virus 304 (a
kind gift by Dr. Kirsi Lehto, University of Turku) using cloned
Pfu polymerase (Stratagene) and oligonucleotides
5'-CTGAATTCATTTAGGTGACACTATAGAATTTTTACAACAATTACCA-3' and
5'-GGTAGCTGTCTGTGTCTAGAATATTGTAATTGTAAATAGT-3'
as upstream and downstream primers, respectively. The upstream primer was designed to contain the SP6 promoter sequence (underlined), and the
downstream primer included the SspI site (underlined). The
polymerase chain reaction fragment digested with EcoRI and XbaI was then gel-purified and ligated with the
EcoRI/XbaI cut vector pUC18 (New England
Biolabs). RNAs were prepared by in vitro transcription of
pGEM3Zf(+) cut with EcoRI (RNA1) or pUC18 cut with
SspI (RNA2). Synthesis of RNA probes was carried out in 50 µl of Promega transcription buffer in the presence of 0.5 mM each NTP (Amersham Pharmacia Biotech), 50 µCi of
either [ -32P] or [ -32P]GTP (Amersham
Pharmacia Biotech; 5000 Ci/mmol), 40 units of RNasin (Promega), 40 units of SP6 RNA polymerase (Promega), and 2.5 to 5 µg of a linear
DNA substrate. After incubation at 37 °C for 1 h, the
transcription products were extracted with phenol/chloroform (1:1) and
purified by PAGE in 10% gels containing 7 M urea.
Radioactive bands were excised, and the RNA was eluted from the gel
with a buffer containing 20 mM Tris-HCl, pH 8.0, 300 mM ammonium acetate, and 1 mM EDTA for 3 h
at room temperature and precipitated with ethanol. To produce RNAs with
lower specific radioactivity, transcription was carried out in 50 µl
of 120 mM HEPES-KOH, pH 7.5, buffer containing 24 mM MgCl2, 1 mM spermidine, 20 mM dithiothreitol, 5 mM each NTP, 50 µCi of
either [ -32P]GTP or [ -32P]GTP, 40 units of RNasin, 80 units of SP6 RNA polymerase, and 5 to 10 µg of a
DNA substrate ( 28). The mixtures were incubated at 37 °C for 2 h, and the reaction was stopped by the addition of 1 unit of DNase RQ
(Promega) per 1 µg of input DNA template. Incubation was continued
for a further 15 min at 37 °C. The resultant RNA samples were
extracted with phenol/chloroform (1:1) and chloroform, precipitated
with 3 M LiCl, and dissolved in sterile water, followed by
additional purification of the RNA preparations in Sephadex G25 spin
columns (Amersham Pharmacia Biotech). RNA concentrations were measured
by absorbance at 260 nm. The purity of the RNAs was controlled PAGE in
10% gel containing 7 M urea.
RNA Triphosphatase Assay--
Two different methods were used to
assay RNA 5'-triphosphatase activity. The first assay was based on the
liberation of the -phosphate group from the -32P-labeled RNA substrates. In this case, the RNA
triphosphatase reaction mixture (40 µl) contained 20 mM
Tris-HCl, pH 8.0, 1 mM MgCl2, 5 mM
KCl, 150 mM NaCl, 2 mM dithiothreitol, and
0.2-5 µmol of a [ -32P]RNA substrate and 0.1-1 pmol
of the enzyme. Reactions were carried out for 20 min at 25 °C. The
reaction products were separated by PAGE as above. The radioactive
bands were visualized by autoradiography. Alternatively, the release of
radioactive phosphate was measured by phosphoimaging (BAS-1500; Fuji)
as the decrease of the radioactivity of the [ -32P]RNA
band. Identical untreated electrophoresed samples served as controls in
each assay.
In the second assay, the terminal GTP at the 5' end of the substrate
RNA was selectively labeled at the -phosphate position during
transcription. The RNA triphosphatase reaction was carried out as above
and stopped by phenol/chloroform extraction. The RNA was precipitated
with ethanol and dissolved in TE buffer (10 mM Tris HCl, pH
8.0, and 1 mM EDTA). The RNA (100 µg/ml) was treated with
RNase T1 (100 units/ml) (Roche Molecular Biochemicals) at 30 °C to
release the 5'-terminal guanylate. Aliquots from the Rnase-treated
samples were spotted onto polyethyleneimine (PEI)- cellulose thin layer
chromatography (TLC) plates (Merck) and developed with 1 M
LiCl. Spots of labeled nucleotides were visualized using autoradiography or phosphoimaging analysis.
GTPase Assay--
Reaction mixtures (10 µl) containing 20 mM Tris-HCl, pH 7.5, 2 mM MgCl2, 5 mM KCl, 150 mM NaCl, 2 mM
dithiothreitol, 50-200 µM GTP, 0.2 µCi of
[ -32P]GTP (Amersham Pharmacia Biotech; 5000 Ci/mM),
and 0.1-1 pmol of enzyme were incubated at 37 °C for 30-60 min.
Aliquots from reaction mixtures were spotted onto PEI-cellulose TLC
plates and developed with 1 M formic acid, 1 M
LiCl. Spots of GTP and the newly formed inorganic phosphate
(Pi) were visualized by autoradiography. Radioactivity in
the Pi spots was also measured by phosphoimaging.
 |
RESULTS |
Nsp2 Is an RNA Triphosphatase--
To test possible RNA
triphosphatase activity of the SFV nonstructural proteins, Nsp1, Nsp2,
Nsp3 and Nsp4 were expressed in E. coli and purified using
metal-chelating chromatography as described before (12). Assay mixtures
containing serial dilutions of the different Nsps were incubated for 30 min at 25 °C in the presence of a 64-nucleotide-long RNA substrate
(RNA1). The 5'-terminal G of the RNA was labeled with
[ -32P]GTP during the transcription. Reaction products
were separated by PAGE under denaturing conditions, and the RNA
triphosphatase activity was measured as a decrease in the intensity of
the labeled RNA band (Fig. 1). Among the
four Nsps tested, only Nsp2 was able to remove the label from the
substrate RNA1 (Fig. 1, Nsp2). The assay was also performed
with the Nsp2 protein containing a single amino acid change (K192N) in
the nucleotide-binding site (Fig. 2).
This mutation has been shown to destroy the NTPase activity of Nsp2
(12). The mutant protein (K192N) had no detectable triphosphatase activity when used within the same concentration range as the wild type
Nsp2 (Fig. 1, K192N).

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 1.
Identification of 5'-RNA triphosphatase
activity of the Alphavirus Nsps.
5'-[ -32P]GTP-RNA1 was synthesized by in
vitro transcription using SP6 polymerase. RNA1 (1 µM) was incubated under standard RNA triphosphatase
reaction conditions with SFV Nsp1, Nsp2, Nsp3, Nsp4, Nsp2 mutant
(K192N), Nsp2-N, Nsp2-C, and SIN Nsp2. Concentrations of purified Nsp
in the reaction mixtures: lanes 1, no protein added;
lanes 2, 8 fmol; lanes 3, 40 fmol; lanes
4, 400 fmol. PAGE was performed in 10% gel in the presence of 7 M urea.
|
|

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 2.
Amino acid sequence of amino-terminal part of
SFV Nsp2 (1 to 470 aa) harboring the RNA triphosphatase and NTPase
activities. Residues representing the conserved NTP binding motif
(1) present in Alphavirus Nsp2 s are underlined.
The critical lysine (Lys-192) residue needed for NTPase (12) and RNA
helicase (14) as well as for RNA triphosphatase activity (in this
study) is shown in boldface.
|
|
To find out which part of the multifunctional Nsp2 harbors the RNA
triphosphatase activity, we expressed and purified two halves of the
Nsp2 molecule separately. The amino-terminal half Nsp2-N (residues
1-470) had similar RNA triphosphatase activity as the complete Nsp2
(Fig. 1, Nsp2-N), whereas the carboxyl-terminal half Nsp2-C
(470-799 aa) had no activity (Fig. 1, Nsp2-C). As expected,
the K192N mutation in the Nsp2-N fragment rendered it inactive (not
shown). Finally, it was interesting to know whether Nsp2 of another
Alphavirus also possessed RNA triphosphatase activity. To
this end, we expressed in E. coli and purified Sindbis virus Nsp2 (Nsp2SIN) following the same protocol as for the SFV
Nsp2. Also, SIN Nsp2 could remove the -labeled phosphate from RNA1 and from [ -32P]GTP (see Fig.
3).

View larger version (39K):
[in this window]
[in a new window]
|
Fig. 3.
Hydrolysis of GTP by SIN Nsp2. Shown is
the PEI-TLC analysis of products of the GTPase reaction catalyzed by
SIN Nsp2. The reaction was carried out in the presence of 0.1 pmol of
SIN Nsp2. Time of incubation: lane 1, 0 min; lane
2, 1 min; lane 3, 2 min; lane 4, 3 min;
lane 5, 5 min; lane 6, 10 min; lane 7,
20 min. GTPase activity was detected as the release of
[ -32P]phosphate (Pi) from
[ -32P]GTP. The positions of Pi and GTP are
indicated. RNA was analyzed as in Fig. 1.
|
|
Nsp2 Hydrolyzes only the , -Triphosphate Bond at the 5' End of
RNA--
Control experiments were devised to exclude the possibility
that the Nsp2 preparation contained nonspecific phosphatase or nuclease
activities. In these experiments, we used a 70-nucleotide-long RNA
molecule representing tobacco mosaic virus leader RNA (RNA2), which
has only a single guanylate residue at the 5' end. During transcription, the 5' end of RNA2 was labeled either with
[ -32P]GTP or [ -32P]GTP (Figs.
4). These RNAs were treated with
different amounts of Nsp2, and the products were analyzed by PAGE. No
decrease in the radioactivity was observed for RNA preparations labeled
at the -position (Fig. 4A), whereas reduction of
radioactivity was clearly seen in Nsp2-treated RNA preparations labeled
at the -position (Fig. 4B). Thus, we conclude that the
Nsp2 preparation did not contain any nonspecific nuclease activity, and
that Nsp2 released -phosphate but not -phosphate from the 5' end
of RNA2.

View larger version (42K):
[in this window]
[in a new window]
|
Fig. 4.
Nsp2 releases 5'
-phosphate from an RNA substrate. The
substrate RNA was synthesized by SP6 transcription in vitro.
The reactions were performed under standard conditions using 1 µmol
of 5'-[ -32P]GTP-terminated RNA2 (A) and
5'-[ 32-P]GTP-terminated RNA2 (B) followed
by treatment with SFV Nsp2. Concentration of SFV Nsp2 in the reaction
mixtures: lanes 1, no protein added; lanes 2, 8 fmol; lanes 3, 400 fmol.
|
|
The following experiment was carried out to ensure that Nsp2 cleaves
only -phosphate but not -phosphate group. RNA2 labeled at the
-position was first exposed to Nsp2. A similar untreated RNA2
preparation served as a control. Both RNA samples were thereafter digested with ribonuclease T1, which can cleave from RNA2 only the
5'-terminal guanylate residue. The digestion mixtures were analyzed by
thin layer chromatography on PEI plates using unlabeled GMP, GDP, and
GTP as markers. The untreated control RNA2 preparation yielded only
radioactive GTP, whereas RNA2 that had been exposed to Nsp2 yielded
radioactive GDP (Fig. 5). Thus, we
conclude that Nsp2 is a genuine RNA triphosphatase that cleaves only
the bond between and phosphates at the 5' end of the substrate
RNA molecule.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 5.
Specificity of Nsp2 RNA triphosphatase.
[ -32P]GTP-labeled RNA2 (with a single G at its 5' end)
was treated with 0.1 pmol of Nsp2 or untreated. The preparations were
digested with RNase T1, and the released guanylate was analyzed by thin
layer chromatography on PEI plates. Time of treatment: lanes
1 and 4, 0 min; lanes 2 and 5, 15 min; lanes 3 and 6, 30 min. The positions of the
origin (ORI) and the nucleotide markers are indicated with
arrows. The labeled -phosphate of the 5'-terminal
guanylate is in boldface.
|
|
Enzymatic Properties of Nsp2 Triphosphatase of SFV--
The RNA
triphosphatase activity was optimized for Nsp2-N fragment with respect
to divalent cation concentration. For comparison, the optimization was
also carried out for the NTPase activity of Nsp2-N using -labeled
GTP as the substrate. The optimal MgCl2 concentration for
the GTPase reaction was 5 mM, and only a slight decrease of
activity was observed with higher concentrations (Fig. 6A, open circles).
Interestingly, there was a sharp maximum at 0.1 mM for
MnCl2 (Fig. 6A, closed symbols). For
RNA triphosphatase, the optimal Mg2+ concentration was
1.0-2.0 mM, whereas a sharp maximum of activity was
obtained with a Mn2+ concentration of 0.1 mM
(Fig. 6B). Our results concerning NaCl dependence indicate
that monovalent cations stimulate the RNA triphosphatase activity but
within a wide concentration range (Fig.
7A). The RNA triphosphatase
activity had a wide pH range with an optimum at pH 7-8 (Fig.
7B). To test the effect of temperature, the rates of
hydrolysis of [ -32P]triphosphate-terminated RNA were
determined at 20 °C, 25 °C, 37 °C, and 42 °C. The maximum
rate of hydrolysis was achieved at 25 °C, whereas incubation at
42 °C apparently resulted in inactivation of the enzyme (Fig.
7C).

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 6.
Divalent cation specificity of SFV GTPase and
RNA triphosphatase. GTPase activity (A) was measured at
0.1 µM GTP, and RNA triphosphatase activity
(B) was measured at 1 µM concentration of the
5'-[ -32P]RNA2 substrate. Reactions were performed in
the presence of 0.1 pmol of Nsp2 and varying concentrations of
MnCl2 ( ) or MgCl2 ( ). The
arrowheads indicate the values obtained in the presence of 1 mM EDTA.
|
|

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 7.
Effects of monovalent cations
(A), pH (B), and temperature
(C) on RNA triphosphatase activity. The RNA
triphosphatase assays were performed using
5'-[ -32P]RNA2 as substrate and 0.1 pmol of Nsp2.
|
|
Knowing the optimal conditions for the RNA triphosphatase and NTPase,
the apparent Km values were estimated for both reactions. The reaction initial velocity, measured within the first 20 min of incubation, was plotted as a function of the substrate concentration according to the equations by Lineweaver and Burk (Fig.
8). The RNA triphosphatase reaction
catalyzed by Nsp2-N reached its maximum at 0.055 µM/min,
and the apparent Km was 2.99 µM (Fig.
8A). Kcat of 5.5 min 1,
determined for the RNA triphosphatase reaction, indicated that the
-phosphate from 5.5 molecules of RNA was hydrolyzed/min. A much
lower apparent substrate affinity (Km value of 90 µM) was obtained for the NTPase activity of Nsp2 (Fig.
8B). The maximal velocity (2.3 µM/min) and the
kinetic constant Kcat (230 min 1)
for the Nsp2-N-catalyzed NTPase reaction were also calculated from the
double-reciprocal Lineweaver-Burk plot. These data indicate that Nsp2-N
of SFV had about a 30-fold higher affinity for RNA than for the
nucleoside triphosphate.

View larger version (10K):
[in this window]
[in a new window]
|
Fig. 8.
Kinetic analysis of RNA triphosphatase and
NTPase activities of SFV Nsp2. Shown is a Lineweaver-Burk plot for
the RNA triphosphatase (A) and NTPase (B)
reaction catalyzed by SFV Nsp2-N. Reaction mixtures contained 0.1 pmol
of Nsp2, and reactions at variable concentrations of substrate RNA and
GTP were performed for 20-min periods. Each data point represents the
average of duplicate reactions. The arrows indicate the
position of ( 1/Km) on the 1/S axis and
( 1/Vmax) on 1/v axis.
|
|
 |
DISCUSSION |
The role of the nonstructural protein Nsp1 in the capping of the
viral RNAs has been well established. First, it was shown that Nsp1 has
guanine-7N-methyltransferase activity (29). However, the
properties of this enzyme were different from those of previously known
capping enzymes. Nsp1 could not methylate an unmethylated cap at the 5'
end of RNA. Instead, it catalyzed the methylation GTP, dGTP, and GpppG,
but not of GpppA, which is the 5' dinucleotide of Alphavirus
42 S and 26 S RNAs (22, 30). This led us to discover a novel
guanylyltransferase activity of Nsp1, which unlike other capping
enzymes, forms a covalent complex with m7GMP instead of GMP
(23, 24). As neither of these reactions takes place in uninfected host
cells, they are potential targets for development of antiviral drugs
(30).
Since removal of -phosphate from the nascent 5' end of RNA is an
essential step in the capping of mRNAs, we started to look for RNA
triphosphatase activity among the virus-specific components of the RNA
polymerase. Here we show that of the four nonstructural proteins of
SFV, only Nsp2 had RNA triphosphatase activity, which was confined to
the amino-terminal half of the protein together with the previously
discovered nucleoside triphosphatase activity (12, 13). To ensure that
the RNA triphosphatase and NTPase activities are properties of the
Alphavirus family, we produced and also assayed Nsp2 of
Sindbis virus. Both activities, indistinguishable from those of SFV
Nsp2, were associated with the Nsp2 of Sindbis virus (Fig. 1,
Nsp2SIN, and Fig. 2). Taking into consideration the
significant amino acid sequence homology among Alphavirus Nsps, one could suggest that Nsp2 proteins of all Alphavirus
have both RNA triphosphatase and NTPase activities.
All viral RNA triphosphatases discovered so far have been shown to have
also NTPase activity (Table I). The
Km values of the RNA triphosphatase and NTPase
activities of vaccinia virus D1 capping protein differ considerably (1 µM and 800 µM, respectively). Competition
between RNA and ATP substrates revealed that ATP inhibited the RNA
triphosphatase reaction, indicating that the hydrolysis of the
-phosphate of both RNA and ATP takes place in the same reaction
center (31). Similar results have been reported for the RNA
triphosphatase/NTPase of Reovirus 1 protein
(32). Our preliminary competition experiments with SFV Nsp2-N with GTP
and RNA substrates showed that the RNA triphosphatase activity was increased rather than decreased in the presence of GTP, strongly suggesting that the NTPase and RNA triphosphatase activities have different reaction centers (data not shown). Mutation in the
NTP-binding site (K192N) abolished both activities, suggesting a close
connection between them. Different reaction centers for NTPase and RNA
triphosphatase have been suggested also for the Flavivirus
West Nile NS3 protein (68 kDa) (38), which also has RNA helicase
activity like Alphavirus Nsp2 (37, 39). Different reaction
centers may be necessary for NS3 and Nsp2, since RNA helicases utilize
the energy released from the hydrolysis of NTPs (14, 40). In contrast
to the RNA triphosphatase activity, which is needed only in the
modification of the 5' end of the nascent RNA, RNA helicase activity is
required throughout the RNA replication cycle. This may mean that
different Nsp2 (and possibly NS3) molecules are involved in these two
processes. One part of Nsp2 molecules would be tightly associated with
Nsp1 in the capping enzyme complex, and the other part could operate alone, perhaps as a homo-oligomer (40), in the RNA helicase function.
This scenario might gain support from the observation that these two
enzymatic activities of Nsp2 differ in respect to the optimal NaCl
concentration. RNA triphosphatase is active in a wide concentration
range (50 to 300 mM), whereas higher than 100 mM concentrations of NaCl were inhibitory for the RNA
helicase function (14).
View this table:
[in this window]
[in a new window]
|
Table I
Properties of RNA triphosphatases
ND, not determined; NTPase, nucleoside triphosphatase; 5'-TP, RNA 5'
triphosphatase; GT, guanylyltransferase.
|
|
Triphosphatases have been classified as metal-dependent and
metal-independent enzymes according to the influence of divalent cations (41). The RNA triphosphatases from mammals, brine shrimp, and
West Nile virus are active in the absence of divalent cations, and
addition of them in fact inhibits triphosphatase activity (33, 42, 43).
Interestingly, a mammalian RNA triphosphatase has been shown to have a
mechanism for phosphoryl group removal similar to that of
protein-tyrosine phosphatases. This class of enzymes does not require
metal ions (Ref. 44 and references therein). Activities of yeast (41),
Reovirus (32), vaccinia virus (21, 45), and baculovirus
LEF-4 (35, 36) RNA triphosphatases are dependent on divalent cations
(Table I). In this respect, Alphavirus RNA triphosphatase is
similar to the other metal-dependent enzymes. However, no
significant homology could be found for the amino-terminal part of Nsp2
with viral or cellular RNA triphosphatases.
Four functions of Alphavirus Nsp2, RNA triphosphatase,
NTPase, RNA helicase, and protease activities, are the same as those of
Flavivirus NS3. However, there is essentially no homology
between NS3 and Nsp2 at the level of amino acid sequences (47).
Moreover, Nsp2 is dependent on divalent cations, whereas NS3 is
stimulated by EDTA. In addition, the RNA triphosphatase activity of
Nsp2 is located at the amino terminus, whereas in NS3 it is in the carboxyl-terminal region of the molecule (37). Thus, our results imply
that the Alphavirus RNA triphosphatase is unique among the RNA triphosphatases and exemplifies a novel divalent
cation-dependent RNA triphosphatase, which is activated by
both Mn2+ and Mg2+ ions.
Recently the three-dimensional structure of the divalent cation
dependent RNA triphosphatase Cet1 of Saccharomyces
cerevisiae has been solved at high resolution. It reveals a tunnel
structure consisting of an eight-stranded antiparallel -barrel into
which the 5' end of the RNA protrudes. The authors (48) propose a mechanism for the specific hydrolysis of the -phosphate as well as
for the binding of Cet1 with the guanylyltransferase subunit (Ceg1).
Essential glutamate residues, conserved in baculovirus LEF 4 and
vaccinia virus D1 RNA triphosphatases, are involved in the metal
binding of Cet1, suggesting structural similarity between these
enzymes. Secondary structure prediction for the amino-terminal part
(1-360 aa) of Nsp2 suggests that it consists mostly of -strands
similarly to Cet1. This region has also clusters of glutamate residues
that could have analogous functions to Glu-305, Glu-307, Glu-492,
Glu-494, and Glu-496 of Cet 1 (48-50).
The composition of the capping apparatus differs between different
species. The tight association of RNA triphosphatase and guanylyltransferase activities in the same protein seems to be a
characteristic feature for most eukaryotic and viral mRNA capping systems. The best characterized vaccinia virus capping enzyme is a
complex of two subunits D1 (95 kDa) and D12 (33 kDa). The RNA
triphosphatase and guanylyltransferase reactions are carried out by the
amino-terminal part of D1, whereas the carboxyl-terminal part together
with D12 is responsible for the methyltransferase activity (21). The
S. cerevisiae capping apparatus consists of three proteins
with RNA triphosphatase (Cet1, 80 kDa), guanylyltransferase (Ceg1, 52 kDa), and methyltransferase (Abd1, 50 kDa) activities (33, 34, 51).
Metazoan species possess a two-component capping apparatus consisting
of a bifunctional RNA triphosphatase/guanylyltransferase polypeptide
(Hce1, 66 kDa) and a separate methyltransferase polypeptide (Hcm1, 52 kDa). The RNA triphosphatase activity is not accompanied by NTPase
activity, unlike other known enzymes (41, 52). In the capping reactions
catalyzed by such enzyme complexes, the order of reactions is RNA
triphosphatase, then guanylyltransferase, and finally
methyltransferase, which methylates the unmethylated cap at the 5' end
of the nascent RNA molecule. According to these results, the
Alphavirus capping apparatus consists of two replicase proteins, Nsp2, having the RNA triphosphatase activity, and Nsp1, with
combined methyltransferase and guanylyltransferase activities. The
guanylyltransferase and methyltransferase reactions take place in
reverse order, as compared with capping of cellular and most other
viral mRNAs.
The Alphavirus capping apparatus is part of an RNA replicase
complex in the cytoplasm of Alphavirus-infected cells. The
complex is tightly bound to the surface of modified endosomes and
lysosomes (53-55) due to interaction of Nsp1 with membrane lipids.
This interaction is mediated by an amphipathic peptide in the middle of
the Nsp1 molecule (46) and strengthened by palmitate chains linked to the carboxyl-terminal cysteine residues 418-420 (25). Attachment of
the RNA polymerase complex to the membranes implies that during the
polymerization of the nascent RNA molecule the template RNA must move
through the fixed polymerase complex. One of the first events during
this process is the capping of the nascent RNA molecule.
 |
ACKNOWLEDGEMENTS |
We thank Airi Sinkko and Tarja
Välimäki for technical assistance and Dr. Marja Makarow and
Dr. Mart Saarma for critical reading of the manuscript.
 |
FOOTNOTES |
*
This work was supported by Academy of Finland Grant 8397, Technology Development Center (TEKES), and Center for International Mobility.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
A Biocentrum Helsinki Fellow. To whom correspondence should be
addressed: Program in Cellular Biotechnology, Institute of Biotechnology, Biocenter Viikki, P. O. Box 56, University of Helsinki, FIN-00014, Helsinki Finland. Tel.: 358-9-191-59400; Fax:
358-9-191-59560; E-mail: leevi.kaariainen@helsinki.fi.
Published, JBC Papers in Press, March 23, 2000, DOI 10.1074/jbc.M910340199
 |
ABBREVIATIONS |
The abbreviations used are:
SFV, Semliki Forest
virus;
aa, amino acids;
NTPase, nucleoside triphosphatase;
PAGE, polyacrylamide gel electrophoresis;
PEI, polyethyleneimine.
 |
REFERENCES |
| 1.
|
Kääriäinen, L.,
Takkinen, K.,
Keränen, S.,
and Söderlund, H.
(1987)
J. Cell Sci. (Supp.)
7,
231-250
|
| 2.
|
Strauss, J. H.,
and Strauss, E. G.
(1994)
Microbiol. Rev.
58,
491-562
|
| 3.
|
Cross, R. K.,
and Gomatos, P. J.
(1981)
Virology
114,
542-554
|
| 4.
|
Dubin, D. T.,
Stollar, V.,
Hsuchen, C.-C.,
Timko, K.,
and Guild, G. M.
(1977)
Virology
77,
457-470
|
| 5.
|
Pettersson, R. F.,
Söderlund, H.,
and Kääriäinen, L.
(1980)
Eur. J. Biochem.
105,
435-443
|
| 6.
|
Wang, H.-L.,
O'Rear, J.,
and Stollar, V.
(1996)
Virology
217,
527-531
|
| 7.
|
Keränen, S.,
and Kääriäinen, L.
(1979)
J. Virol.
32,
19-29
|
| 8.
|
Barton, D. J.,
Sawicki, S. G.,
and Sawicki, D. L.
(1988)
J. Virol.
62,
3597-3602
|
| 9.
|
Peränen, J.,
Takkinen, K.,
Kalkkinen, N.,
and Kääriäinen, L.
(1988)
J. Gen. Virol.
69,
2165-2178
|
| 10.
|
LaStarza, M. W.,
Lemm, J. A.,
and Rice, C. M.
(1994)
J. Virol.
68,
5781-5791
|
| 11.
|
Wang, Y.-F.,
Sawicki, S. G.,
and Sawicki, D. L.
(1994)
J. Virol.
68,
6466-6475
|
| 12.
|
Rikkonen, M.,
Peränen, J.,
and Kääriäinen, L.
(1994)
J. Virol.
68,
5804-5810
|
| 13.
|
Rikkonen, M.
(1996)
Virology
218,
352-361
|
| 14.
|
Gomez de Cedron, M.,
Ehsani, N.,
Mikkola, M.,
Garcia, J. A.,
and Kääriäinen, L.
(1999)
FEBS Lett.
448,
19-22
|
| 15.
|
Hardy, W. R.,
and Strauss, J. H.
(1989)
J. Virol.
63,
4653-4664
|
| 16.
|
Takkinen, K.,
Peränen, J.,
and Kääriäinen, L.
(1991)
J. Gen. Virol.
72,
1627-1633
|
| 17.
|
Peränen, J.,
Rikkonen, M.,
Liljeström, P.,
and Kääriäinen, L.
(1990)
J. Virol.
64,
1888-1896
|
| 18.
|
Rikkonen, M.,
Peränen, J.,
and Kääriäinen, L.
(1992)
Virology
189,
462-473
|
| 19.
|
Suopanki, J.,
Sawicki, D. L.,
Sawicki, S. G.,
and Kääriäinen, L.
(1998)
J. Gen. Virol.
79,
309-319
|
| 20.
|
Mizumoto, K.,
and Kaziro, Y.
(1987)
Prog. Nucleic Acid Res. Mol. Biol.
34,
1-28
|
| 21.
|
Shuman, S.
(1995)
Prog. Nucleic Acid Res. Mol. Biol.
50,
101-129
|
| 22.
|
Laakkonen, P.,
Hyvönen, M.,
Peränen, J.,
and Kääriäinen, L.
(1994)
J. Virol.
68,
7418-7425
|
| 23.
|
Ahola, T.,
and Kääriäinen, L.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
507-511
|
| 24.
|
Ahola, T.,
Laakkonen, P.,
Vihinen, H.,
and Kääriäinen, L.
(1997)
J. Virol.
71,
392-397
|
| 25.
|
Laakkonen, P.,
Ahola, T.,
and Kääriäinen, L.
(1996)
J. Biol. Chem.
271,
28567-28571
|
| 26.
|
Peränen, J.,
Rikkonen, M.,
Hyvönen, M.,
and Kääriäinen, L.
(1996)
Anal. Biochem.
236,
371-373
|
| 27.
|
Bradford, M. M.
(1976)
Anal. Biochem.
72,
248-254
|
| 28.
|
Gurevich, V. V.,
Pokrovskaya, I. D.,
Obukhova, T. A,
and Zozulya, S. A.
(1991)
Anal. Biochem.
195,
207-213
|
| 29.
|
Mi, S.,
and Stollar, V.
(1991)
Virology
184,
423-427
|
| 30.
|
Lampio, A.,
Ahola, T.,
Darzynkiewicz, E.,
Stepinski, J.,
Jankowska-Anyszka, M.,
and Kääriäinen, L.
(1999)
Antiviral Res.
42,
35-46
|
| 31.
|
Myette, J. R.,
and Niles, E. G.
(1996)
J. Biol. Chem.
271,
11945-11952
|
| 32.
|
Bisaillon, M.,
and Lemay, G.
(1997)
J. Biol. Chem.
272,
29954-29957
|
| 33.
|
Itoh, N.,
Mizumoto, K.,
and Kaziro, Y.
(1984)
J. Biol. Chem.
259,
13930-13936
|
| 34.
|
Itoh, N.,
Yamada, H.,
Kaziro, Y.,
and Mizumoto, K.
(1987)
J. Biol. Chem.
262,
1989-1995
|
| 35.
|
Gross, C. H.,
and Shuman, S.
(1998)
J. Virol.
72,
10020-10028
|
| 36.
|
Jin, J.,
Dong, W.,
and Guarino, L. A.
(1998)
J. Virol.
72,
10003-10010
|
| 37.
|
Wengler, G.,
and Wengler, G.
(1991)
Virology
184,
707-715
|
| 38.
|
Wengler, G.,
and Wengler, G.
(1993)
Virology
197,
265-273
|
| 39.
|
Gallinari, P.,
Brennan, D.,
Nardi, C.,
Brunetti, M.,
Tomei, L.,
Steinkuhler, C.,
and de Francesco, R.
(1998)
J. Virol.
72,
6758-6769
|
| 40.
|
Bird, L. E.,
Subramanya, H. S.,
and Wigley, D. B.
(1998)
Curr. Opin. Struct. Biol.
8,
14-18
|
| 41.
|
Ho, C. K.,
Pei, Y.,
and Shuman, S.
(1998)
J. Biol. Chem.
273,
34151-34156
|
| 42.
|
Yagi, Y.,
Mizumoto, K.,
and Kaziro, Y.
(1983)
EMBO J.
2,
611-615
|
| 43.
|
Yagi, Y.,
Mizumoto, K.,
and Kaziro, Y.
(1984)
J. Biol. Chem.
259,
4695-4698
|
| 44.
|
Wen, Y.,
Yue, Z.,
and Shatkin, A.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
12226-12231
|
| 45.
|
Shuman, S.,
and Moss, B.
(1990)
Methods Enzymol.
181,
170-180
|
| 46.
|
Ahola, T.,
Lampio, A.,
Auvinen, P.,
and Kääriäinen, L.
(1999)
EMBO J.
18,
3164-3172
|
| 47.
|
Koonin, E. V.,
and Dolja, V. V.
(1993)
Crit. Rev. Biochem. Mol. Biol.
28,
375-430
|
| 48.
|
Lima, C. D.,
Wang, L. K.,
and Shuman, S.
(1999)
Cell
99,
533-543
|
| 49.
|
Lehman, K.,
Schwer, B.,
Ho, C. K.,
Rouzankina, I.,
and Shuman, S.
(1999)
J. Biol. Chem.
274,
22668-22678
|
| 50.
|
Pei, Y.,
Ho, C. K.,
Schwer, B.,
and Shuman, S.
(1999)
J. Biol. Chem.
274,
28865-28874
|
| 51.
|
Shibagaki, Y.,
Itoh, N.,
Yamada, H.,
Nagata, S.,
and Mizumoto, K.
(1992)
J. Biol. Chem.
267,
9521-9528
|
| 52.
|
Saha, N.,
Schwer, B.,
and Shuman, S.
(1999)
J. Biol. Chem.
274,
16553-16562
|
| 53.
|
Froshauer, S.,
Kartenbeck, J.,
and Helenius, A.
(1988)
J. Cell Biol.
107,
2075-2086
|
| 54.
|
Peränen, J.,
and Kääriäinen, L.
(1991)
J. Virol.
65,
1623-1627
|
| 55.
|
Peränen, J.,
Laakkonen, P.,
Hyvönen, M.,
and Kääriäinen, L.
(1995)
Virology
208,
610-620
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Gopinath and M. S. Shaila
RNA triphosphatase and guanylyl transferase activities are associated with the RNA polymerase protein L of rinderpest virus
J. Gen. Virol.,
July 1, 2009;
90(7):
1748 - 1756.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Lulla, D. L. Sawicki, S. G. Sawicki, A. Lulla, A. Merits, and T. Ahola
Molecular Defects Caused by Temperature-Sensitive Mutations in Semliki Forest Virus nsP1
J. Virol.,
September 15, 2008;
82(18):
9236 - 9244.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Mayuri, T. W. Geders, J. L. Smith, and R. J. Kuhn
Role for Conserved Residues of Sindbis Virus Nonstructural Protein 2 Methyltransferase-Like Domain in Regulation of Minus-Strand Synthesis and Development of Cytopathic Infection
J. Virol.,
August 1, 2008;
82(15):
7284 - 7297.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Tamm, A. Merits, and I. Sarand
Mutations in the nuclear localization signal of nsP2 influencing RNA synthesis, protein expression and cytotoxicity of Semliki Forest virus
J. Gen. Virol.,
March 1, 2008;
89(3):
676 - 686.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. F. Souliere, J.-P. Perreault, and M. Bisaillon
Magnesium-binding studies reveal fundamental differences between closely related RNA triphosphatases
Nucleic Acids Res.,
February 2, 2008;
36(2):
451 - 461.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Montgomery and R. E. Johnston
Nuclear Import and Export of Venezuelan Equine Encephalitis Virus Nonstructural Protein 2
J. Virol.,
October 1, 2007;
81(19):
10268 - 10279.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. P. Su, J. H. Shien, H. J. Liu, H. S. Yin, and L. H. Lee
Avian reovirus core protein {micro}A expressed in Escherichia coli possesses both NTPase and RTPase activities
J. Gen. Virol.,
June 1, 2007;
88(6):
1797 - 1805.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Atasheva, R. Gorchakov, R. English, I. Frolov, and E. Frolova
Development of Sindbis Viruses Encoding nsP2/GFP Chimeric Proteins and Their Application for Studying nsP2 Functioning
J. Virol.,
May 15, 2007;
81(10):
5046 - 5057.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Balistreri, J. Caldentey, L. Kaariainen, and T. Ahola
Enzymatic Defects of the nsP2 Proteins of Semliki Forest Virus Temperature-Sensitive Mutants
J. Virol.,
March 15, 2007;
81(6):
2849 - 2860.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Lulla, V. Lulla, K. Tints, T. Ahola, and A. Merits
Molecular determinants of substrate specificity for semliki forest virus nonstructural protease.
J. Virol.,
June 1, 2006;
80(11):
5413 - 5422.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Garmashova, R. Gorchakov, E. Frolova, and I. Frolov
Sindbis Virus Nonstructural Protein nsP2 Is Cytotoxic and Inhibits Cellular Transcription.
J. Virol.,
June 1, 2006;
80(12):
5686 - 5696.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. E. Galbraith, B. J. Sheahan, and G. J. Atkins
Deletions in the hypervariable domain of the nsP3 gene attenuate Semliki Forest virus virulence.
J. Gen. Virol.,
April 1, 2006;
87(Pt 4):
937 - 947.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Lulla, A. Merits, P. Sarin, L. Kaariainen, S. Keranen, and T. Ahola
Identification of Mutations Causing Temperature-Sensitive Defects in Semliki Forest Virus RNA Synthesis
J. Virol.,
March 15, 2006;
80(6):
3108 - 3111.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. L. Sawicki, S. Perri, J. M. Polo, and S. G. Sawicki
Role for nsP2 Proteins in the Cessation of Alphavirus Minus-Strand Synthesis by Host Cells
J. Virol.,
January 1, 2006;
80(1):
360 - 371.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Wang, W.-M. Lee, T. Watanabe, M. Schwartz, M. Janda, and P. Ahlquist
Brome Mosaic Virus 1a Nucleoside Triphosphatase/Helicase Domain Plays Crucial Roles in Recruiting RNA Replication Templates
J. Virol.,
November 1, 2005;
79(21):
13747 - 13758.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-L. Li, Y.-H. Lin, H. A. Simmonds, and V. Stollar
A Mutant of Sindbis Virus Which Is Able To Replicate in Cells with Reduced CTP Makes a Replicase/Transcriptase with a Decreased Km for CTP
J. Virol.,
September 15, 2004;
78(18):
9645 - 9651.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Ivanov and J. Ziebuhr
Human Coronavirus 229E Nonstructural Protein 13: Characterization of Duplex-Unwinding, Nucleoside Triphosphatase, and RNA 5'-Triphosphatase Activities
J. Virol.,
July 15, 2004;
78(14):
7833 - 7838.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Ivanov, V. Thiel, J. C. Dobbe, Y. van der Meer, E. J. Snijder, and J. Ziebuhr
Multiple Enzymatic Activities Associated with Severe Acute Respiratory Syndrome Coronavirus Helicase
J. Virol.,
June 1, 2004;
78(11):
5619 - 5632.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Fayzulin and I. Frolov
Changes of the Secondary Structure of the 5' End of the Sindbis Virus Genome Inhibit Virus Growth in Mosquito Cells and Lead to Accumulation of Adaptive Mutations
J. Virol.,
May 15, 2004;
78(10):
4953 - 4964.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Kim, J. S. L. Parker, K. E. Murray, and M. L. Nibert
Nucleoside and RNA Triphosphatase Activities of Orthoreovirus Transcriptase Cofactor {micro}2
J. Biol. Chem.,
February 6, 2004;
279(6):
4394 - 4403.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. De, C. Fata-Hartley, S. G. Sawicki, and D. L. Sawicki
Functional Analysis of nsP3 Phosphoprotein Mutants of Sindbis Virus
J. Virol.,
December 15, 2003;
77(24):
13106 - 13116.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Vasiljeva, A. Merits, A. Golubtsov, V. Sizemskaja, L. Kaariainen, and T. Ahola
Regulation of the Sequential Processing of Semliki Forest Virus Replicase Polyprotein
J. Biol. Chem.,
October 24, 2003;
278(43):
41636 - 41645.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Tuittila and A. E. Hinkkanen
Amino acid mutations in the replicase protein nsP3 of Semliki Forest virus cumulatively affect neurovirulence
J. Gen. Virol.,
June 1, 2003;
84(6):
1525 - 1533.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Salonen, L. Vasiljeva, A. Merits, J. Magden, E. Jokitalo, and L. Kaariainen
Properly Folded Nonstructural Polyprotein Directs the Semliki Forest Virus Replication Complex to the Endosomal Compartment
J. Virol.,
February 1, 2003;
77(3):
1691 - 1702.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. T. Heise, L. J. White, D. A. Simpson, C. Leonard, K. A. Bernard, R. B. Meeker, and R. E. Johnston
An Attenuating Mutation in nsP1 of the Sindbis-Group Virus S.A.AR86 Accelerates Nonstructural Protein Processing and Up-Regulates Viral 26S RNA Synthesis
J. Virol.,
December 20, 2002;
77(2):
1149 - 1156.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. I. Frolova, R. Z. Fayzulin, S. H. Cook, D. E. Griffin, C. M. Rice, and I. Frolov
Roles of Nonstructural Protein nsP2 and Alpha/Beta Interferons in Determining the Outcome of Sindbis Virus Infection
J. Virol.,
October 11, 2002;
76(22):
11254 - 11264.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Vlot, A. Menard, and J. F. Bol
Role of the Alfalfa Mosaic Virus Methyltransferase-Like Domain in Negative-Strand RNA Synthesis
J. Virol.,
October 11, 2002;
76(22):
11321 - 11328.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. K. Fazakerley, A. Boyd, M. L. Mikkola, and L. Kaariainen
A Single Amino Acid Change in the Nuclear Localization Sequence of the nsP2 Protein Affects the Neurovirulence of Semliki Forest Virus
J. Virol.,
January 1, 2002;
76(1):
392 - 396.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-I. Li, T.-W. Shih, Y.-H. Hsu, Y.-T. Han, Y.-L. Huang, and M. Meng
The Helicase-Like Domain of Plant Potexvirus Replicase Participates in Formation of RNA 5' Cap Structure by Exhibiting RNA 5'-Triphosphatase Activity
J. Virol.,
December 15, 2001;
75(24):
12114 - 12120.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Kujala, A. Ikäheimonen, N. Ehsani, H. Vihinen, P. Auvinen, and L. Kääriäinen
Biogenesis of the Semliki Forest Virus RNA Replication Complex
J. Virol.,
April 15, 2001;
75(8):
3873 - 3884.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Merits, L. Vasiljeva, T. Ahola, L. Kääriäinen, and P. Auvinen
Proteolytic processing of Semliki Forest virus-specific non-structural polyprotein by nsP2 protease
J. Gen. Virol.,
April 1, 2001;
82(4):
765 - 773.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
H. Vihinen and J. Saarinen
Phosphorylation Site Analysis of Semliki Forest Virus Nonstructural Protein 3
J. Biol. Chem.,
September 1, 2000;
275(36):
27775 - 27783.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Vihinen, T. Ahola, M. Tuittila, A. Merits, and L. Kaariainen
Elimination of Phosphorylation Sites of Semliki Forest Virus Replicase Protein nsP3
J. Biol. Chem.,
February 16, 2001;
276(8):
5745 - 5752.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Vasiljeva, L. Valmu, L. Kaariainen, and A. Merits
Site-specific Protease Activity of the Carboxyl-terminal Domain of Semliki Forest Virus Replicase Protein nsP2
J. Biol. Chem.,
August 10, 2001;
276(33):
30786 - 30793.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|